Shore Medical Center announced that its Cancer Center, a member of the Penn Cancer Network, has been reaccredited by the Commission on Cancer with zero deficiencies.
The CoC, a voluntary quality program of the American College of Surgeons, focuses on maintaining the highest standards of quality and safety in Oncology Programs.
To achieve accreditation, cancer programs must meet 34 quality of care standards established by the CoC, undergo comprehensive evaluations every three years, and consistently deliver exceptional patient centered care across multiple disciplines.
The recent reaccreditation of Shore Cancer Center is a testament to the dedication and collaborative efforts of the entire Cancer Center team, spanning numerous disciplines, a news release stated. Each individual’s contribution played a vital role in meeting and surpassing the CoC’s rigorous standards.
Manager of Radiation Oncology Kimberly Kaczmarski and pathologist and Cancer Committee Chairman Dr. James Pond were cited for their work spearheading the CoC accreditation process and providing guidance throughout the process.
“This achievement showcases our unwavering dedication to delivering outstanding care to our patients and upholding the highest standards of quality and safety,” said Matthew Piskun, director of Pharmacy, Oncology and Infusion Services. “We extend our sincere appreciation to every individual who contributed to this success and reaffirm our commitment to providing comprehensive, patient-centered care.”
Shore Cancer Center is committed to advancing cancer care, staying at the forefront of medical advancements, and continuously improving patient outcomes, the release said.
For more information about Shore Cancer Center and its services, see https://shoremedicalcenter.org/centers/cancer or call 609-653-3585.
